Jeerangsapasuk Wankawee, Charoenpitakchai Mongkon, Sornwiboonsak Pakpiengpen, Chatkrailert Aphichat
Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
60th Anniversary HRH Maha Chakri Sirindhorn Hemodialysis Center, Thammasat University Hospital, Pathumthani, Thailand.
Nephrology (Carlton). 2025 Jan;30(1):e14429. doi: 10.1111/nep.14429.
The case report presents a male patient in his mid-60s with a history of hypertension, benign prostatic hyperplasia and chronic kidney disease (CKD). He presented with gradually increasing serum creatinine levels and hyperglobulinemia, leading to suspicion of multiple myeloma. However, subsequent testing revealed features consistent with systemic lupus erythematosus (SLE) and IgG4-related kidney disease (IgG4-RKD). The patient's laboratory results included anaemia, positive ANA and anti-dsDNA and elevated serum IgG4 levels. A kidney biopsy showed extensive interstitial fibrosis, plasma cell infiltration and a high number of IgG4-positive plasma cells, suggesting the diagnosis of IgG4-RKD overlapping with SLE. Treatment involved prednisolone, mycophenolate mofetil for IgG4-RKD and hydroxychloroquine for SLE. The patient's case highlights the challenges in diagnosing overlapping IgG4-RKD and SLE. The current criteria for diagnosing these diseases may be complicated by atypical presentations, leading to potential diagnostic confusion. This report underscores the importance of histopathological confirmation and comprehensive diagnostic criteria to differentiate between overlapping autoimmune conditions. Immunosuppressive therapy remains the cornerstone for managing both IgG4-related disease and SLE, with treatment tailored based on disease severity and organ involvement. The patient's response to treatment and follow-up monitoring are crucial for assessing outcomes and adjusting management to minimise disease relapse and therapy-related complications.
该病例报告介绍了一名60多岁的男性患者,有高血压、良性前列腺增生和慢性肾脏病(CKD)病史。他出现血清肌酐水平逐渐升高和高球蛋白血症,引发了多发性骨髓瘤的怀疑。然而,随后的检测显示出与系统性红斑狼疮(SLE)和IgG4相关性肾脏病(IgG4-RKD)一致的特征。患者的实验室检查结果包括贫血、抗核抗体(ANA)和抗双链DNA(anti-dsDNA)阳性以及血清IgG4水平升高。肾脏活检显示广泛的间质纤维化、浆细胞浸润以及大量IgG4阳性浆细胞,提示诊断为IgG4-RKD合并SLE。治疗包括使用泼尼松龙、霉酚酸酯治疗IgG4-RKD以及使用羟氯喹治疗SLE。该患者的病例突出了诊断IgG4-RKD与SLE重叠时的挑战。当前这些疾病的诊断标准可能因非典型表现而变得复杂,导致潜在的诊断困惑。本报告强调了组织病理学确认和全面诊断标准对于区分重叠自身免疫性疾病的重要性。免疫抑制治疗仍然是管理IgG4相关疾病和SLE的基石,治疗方案根据疾病严重程度和器官受累情况进行调整。患者对治疗的反应以及随访监测对于评估预后和调整管理以尽量减少疾病复发和治疗相关并发症至关重要。